Biogen, Inc. (BIIB)

183.92 -4.13 (-2.20%) USD  |  NASDAQ  |  Mar 03, 16:00
183.92 0.00 (0.00%) After-Hours: 16:39
More

Biogen Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade